# Stress Hydrocortisone In Pediatric Septic Shock

> **NCT03401398** · PHASE3 · RECRUITING · sponsor: **Jerry Zimmerman** · enrollment: 500 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Hydrocortisone, sodium succinate
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03401398
- **Lead sponsor:** Jerry Zimmerman
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-11
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03401398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03401398, "Stress Hydrocortisone In Pediatric Septic Shock". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03401398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*